Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 2/2019

01-03-2019 | Original Paper

The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study

Authors: Virva Hyttinen, Johanna Jyrkkä, Leena K. Saastamoinen, Anna-Kaisa Vartiainen, Hannu Valtonen

Published in: The European Journal of Health Economics | Issue 2/2019

Login to get access

Abstract

Aims

To determine (1) whether potentially inappropriate medication (PIM) use defined by the Meds75 + database is associated with fracture-specific hospitalisations and all-cause mortality, and (2) the association between PIM use and all-cause hospitalisation costs in a 12-year follow-up of a nationwide sample of people aged ≥ 65 years in Finland.

Methods

This is a longitudinal study of 20,666 community-dwelling older persons with no prior purchases of PIMs within a 2-year period preceding the index date (1 Jan 2002), who were followed until the end of 2013. Data were obtained from the Finnish Prescription Register, and it was accompanied by information on inpatient care, causes of deaths and socioeconomic status from other national registers. Propensity score matching (PSM) analysis was used to account for potential selection effect in PIM use. Cox proportional hazards regression was used to identify the time to the first fracture or death by comparing PIM-users (n = 10,333) with non-users (n = 10,333). The association between PIM use and hospital costs was analysed with a fixed effects linear model.

Results

PIM use was weakly associated with an increased risk of fractures and death. The association was stronger in the first PIM-use periods. Hospitalised PIM-users had 15% higher hospital costs compared to non-users during the 12-year follow-up.

Conclusion

PIM initiation was associated with an increased risk of fracture-specific hospitalisation and mortality and PIM-users had higher hospital costs than non-users. Health care providers should carefully consider these issues when prescribing PIM for older persons.
Appendix
Available only for authorised users
Literature
1.
Beers, M.H., Ouslander, J.G., Rollingher, I., Reuben, D.B., Brooks, J., Beck, J.C.: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch. Intern. Med. 151(9), 1825–1832 (1991)CrossRefPubMed
2.
Tommelein, E., Mehuys, E., Petrovic, M., Somers, A., Colin, P., Boussery, K.: Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur. J. Clin. Pharmacol. 71(12), 1415–1427 (2015)CrossRefPubMed
3.
Leikola, S., Dimitrow, M., Lyles, A., Pitkälä, K., Airaksinen, M.: Potentially inappropriate medication use among Finnish non-institutionalized people aged ≥ 65 years: a register-based, cross-sectional, national study. Drugs Aging 28(3), 227–236 (2011)CrossRefPubMed
4.
Bell, J.S., Ahonen, J., Lavikainen, P., Hartikainen, S.: Potentially inappropriate drug use among older persons in Finland: application of a new national categorization. Eur. J. Clin. Pharmacol. 69(3), 657–664 (2013)CrossRefPubMed
5.
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 63(11), 2227–2246 (2015)CrossRef
6.
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M.N., Ryan, C., Gallagher, P.: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2), 213–218 (2015)CrossRefPubMed
7.
Holt, S., Schmiedl, S., Thürmann, P.A.: Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch. Arztebl. Int. 107(31–32), 543–551 (2010)PubMedCentralPubMed
8.
Renom-Guiteras, A., Meyer, G., Thürmann, P.A.: The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur. J. Clin. Pharmacol. 71(7), 861–875 (2015)CrossRefPubMedCentralPubMed
9.
10.
Hedna, K., Hakkarainen, K.M., Gyllensten, H., Jonsson, A.K., Petzold, M., Hagg, S.: Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur. J. Clin. Pharmacol. 71, 1525–1533 (2015)CrossRefPubMedCentralPubMed
11.
Berdot, S., Bertrand, M., Dartigues, J., Fourrier, A., Tavernier, B., Ritchie, K., Alpérovitch, A.: Inappropriate medication use and risk of falls—a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 9, 30–30 (2009)CrossRefPubMedCentralPubMed
12.
Narayan, S.W., Nishtala, P.S.: Associations of potentially inappropriate medicine use with fall-related hospitalisations and primary care visits in older New Zealanders: a population-level study using the updated 2012 beers criteria. Drugs Real World Outcomes 2(2), 137–141 (2015)CrossRefPubMedCentralPubMed
13.
Endres, H.G., Kaufmann-Kolle, P., Steeb, V., Bauer, E., Böttner, C., Thürmann, P.: Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS One 12(2), e0146811 (2015)CrossRef
14.
Henschel, F., Redaelli, M., Siegel, M., Stock, S.: Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list. Drugs Real World Outcomes 2(3), 249–259 (2015)CrossRefPubMedCentralPubMed
15.
Hyttinen, V., Jyrkkä, J., Valtonen, H.: A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care 54(10), 950–964 (2016)CrossRefPubMed
16.
Heider, D., Matschinger, H., Meid, A.D., Quinzler, R., Adler, J.B., Günster, C., Haefeli, W.E., König, H.H.: Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: Retrospective Matched Cohort Study. Drugs Aging 34(4), 289–301 (2017)CrossRefPubMed
17.
do Nascimento, M.,M., Mambrini, J.V., Lima-Costa, M.F., Firmo, J.O., Peixoto, S.W., de Loyola Filho, A.I.: Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. Eur. J. Clin. Pharmacol. 73(5), 615–621 (2017)CrossRefPubMed
18.
Klarin, I., Wimo, A., Fastbom, J.: The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22(1), 69–82 (2005)CrossRefPubMed
19.
Chen, C.C., Cheng, S.H.: Potentially inappropriate medication and health care outcomes: an instrumental variable approach. Health Serv. Res. 51(4), 1670–1691 (2016)CrossRefPubMed
20.
21.
22.
23.
24.
Li, M.: Using the propensity score method to estimate causal effects: a review and practical guide. Organ. Res. Methods 16(2), 188–226 (2013)CrossRef
25.
Caliendo, M., Kopeinig, S.: Some practical guidance for the implementation of propensity score matching. J. Econ. Surv. 22(1), 31–72 (2008)CrossRef
26.
Hyttinen, V., Taipale, H., Tanskanen, A., Tiihonen, J., Tolppanen, A.M., Hartikainen, S., Valtonen, H.: Risk factors for initiation of potentially inappropriate medications in community-dwelling older adults with and without Alzheimer’s disease. Drugs Aging 34(1), 67–77 (2017)CrossRefPubMed
27.
Bradburn, M.J., Clark, T.G., Love, S.B., Altman, D.G.: Survival analysis Part II: multivariate data analysis—an introduction to concepts and methods. Br. J. Cancer 89(3), 431–436 (2003)CrossRefPubMedCentralPubMed
28.
Forma, L., Rissanen, P., Aaltonen, M., Raitanen, J., Jylha, M.: Age and closeness of death as determinants of health and social care utilization: a case-control study. Eur. J. Pub. Health 19(3), 313–318 (2009)CrossRef
29.
Reich, O., Rosemann, T., Rapold, R., Blozik, E., Senn, O.: Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One 9(8), e105425 (2014)CrossRefPubMedCentralPubMed
30.
Varga, S., Alcusky, M., Keith, S.W., Hegarty, S.E., Canale, D., Lombardi, S., Maio, M.V.: Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 83, 2572–2580 (2017)CrossRefPubMedCentralPubMed
31.
Lu, W.H., Wen, Y.W., Chen, L.K., Hsiao, F.Y.: Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ 187(4), E130–E137 (2015)CrossRefPubMedCentralPubMed
32.
Hyttinen, V., Taipale, H., Tolppanen, A.M., Tanskanen, A., Tiihonen, J., Hartikainen, S., Valtonen, H.: Incident use of a potentially inappropriate medication and hip fracture in community-dwelling older persons with Alzheimer’s Disease. Ann. Pharmacother. 51(9), 725–734 (2017)CrossRefPubMed
33.
Jano, E., Aparasu, R.R.: Healthcare outcomes associated with Beers’ criteria: a systematic review. Ann. Pharmacother. 41(3), 438–448 (2007)CrossRefPubMed
34.
Muhlack, D.C., Hoppe, L.K., Weberpals, J., Brenner, H., Schottker, B.: The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J. Am. Med. Dir. Assoc. 18(3), 211–220 (2017)CrossRefPubMed
35.
Fu, A.Z., Jiang, J.Z., Reeves, J.H., Fincham, J.E., Liu, G.G., Perri, M.: Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care 45(5), 472–476 (2007)CrossRefPubMed
36.
Furu, K., Wettermark, B., Andersen, M., Martikainen, J.E., Almarsdottir, A.B., Sorensen, H.T.: The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin. Pharmacol. Toxicol. 106(2), 86–94 (2010)CrossRefPubMed
37.
Ray, W.A.: Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158(9), 915–920 (2003)CrossRefPubMed
38.
Rikala, M., Hartikainen, S., Sulkava, R., Korhonen, M.J.: Validity of the finnish prescription register for measuring psychotropic drug exposures among elderly Finns: a population-based intervention study. Drugs Aging 27(4), 337–349 (2010)CrossRefPubMed
Metadata
Title
The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study
Authors
Virva Hyttinen
Johanna Jyrkkä
Leena K. Saastamoinen
Anna-Kaisa Vartiainen
Hannu Valtonen
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 2/2019
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-018-0992-0

Other articles of this Issue 2/2019

The European Journal of Health Economics 2/2019 Go to the issue

Original Paper

Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries

Original Paper

Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care: an economic evaluation

Original Paper

Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany

Original Paper

Design and effects of outcome-based payment models in healthcare: a systematic review

Editorial

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

Original Paper

Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?